Plasma heme oxygenase-1 concentration in relation to impaired glucose regulation in a non-diabetic chinese population

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Bao, Wei ^a   Rong, Shuang ^a   Zhang, Muxun ^a   Yu, Xuefeng ^a   Zhao, Yanting ^a   Xiao, Xiao ^a   Yang, Wei ^a   Wang, Di ^a   Yao, Ping ^a   Hu, Frank B ^b   Liu, Liegang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEME OXYGENASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; HEME OXYGENASE 1 BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE REGULATION; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SMOKING; AREA UNDER THE CURVE; ASIAN; BLOOD; GLUCOSE INTOLERANCE; NONPARAMETRIC TEST; STATISTICAL MODEL;

AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE INTOLERANCE; HEME OXYGENASE-1; HUMANS; LOGISTIC MODELS; ROC CURVE; STATISTICS, NONPARAMETRIC;

EID: 84862184984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032223     Document Type: Article

References (26)

1. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, et al. (2001) Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 285: 2109-2113.
2. Unwin N, Shaw J, Zimmet P, Alberti KG, (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19: 708-723.
3. Evans JL, Goldfine ID, Maddux BA, Grodsky GM, (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52: 1-8.
4. Song F, Jia W, Yao Y, Hu Y, Lei L, et al. (2007) Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin Sci (Lond) 112: 599-606.
5. Platt JL, Nath KA, (1998) Heme oxygenase: protective gene or Trojan horse. Nat Med 4: 1364-1365.
6. Ryter SW, Alam J, Choi AM, (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650.
7. Morse D, Choi AM, (2002) Heme oxygenase-1: the "emerging molecule" has arrived. Am J Respir Cell Mol Biol 27: 8-16.
8. Abraham NG, Kappas A, (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127.
9. Bao W, Song F, Li X, Rong S, Yang W, et al. (2010) Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus. PLoS One 5: e12371.
10. Caselli C, Cabiati M, Prescimone T, Del Ry S, Pardini S, et al. (2011) Heme oxygenase-1 in patients with idiopathic left ventricular and coronary microvascular dysfunction: Relationship with diabetes/insulin resistance. European Heart Journal 32: 1092.
11. Okuhara K, Kisaka T, Ozono R, Kurisu S, Inoue I, et al. (2010) Change in bilirubin level following acute myocardial infarction is an index for heme oxygenase activation. South Med J 103: 876-881.
12. Sato T, Takeno M, Honma K, Yamauchi H, Saito Y, et al. (2006) Heme oxygenase-1, a potential biomarker of chronic silicosis, attenuates silica-induced lung injury. Am J Respir Crit Care Med 174: 906-914.
13. Mateo I, Infante J, Sanchez-Juan P, Garcia-Gorostiaga I, Rodriguez-Rodriguez E, et al. (2010) Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease. Acta Neurol Scand 121: 136-138.
14. Saukkonen K, Lakkisto P, Kaunisto MA, Varpula M, Voipio-Pulkki LM, et al. (2010) Heme oxygenase 1 polymorphisms and plasma concentrations in critically ill patients. Shock 34: 558-564.
15. Alberti KG, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
17. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 (Suppl 1): S5-20.
18. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350.
19. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403.
20. Jonas JC, Guiot Y, Rahier J, Henquin JC, (2003) Haeme-oxygenase 1 expression in rat pancreatic beta cells is stimulated by supraphysiological glucose concentrations and by cyclic AMP. Diabetologia 46: 1234-1244.
21. Won KC, Moon JS, Eun MJ, Yoon JS, Chun KA, et al. (2006) A protective role for heme oxygenase-1 in INS-1 cells and rat islets that are exposed to high glucose conditions. J Korean Med Sci 21: 418-424.
22. Tiedge M, Lortz S, Drinkgern J, Lenzen S, (1997) Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46: 1733-1742.
23. Lee TS, Chau LY, (2002) Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8: 240-246.
24. Schipper HM, Chertkow H, Mehindate K, Frankel D, Melmed C, et al. (2000) Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology 54: 1297-1304.
25. Kolberg JA, Jorgensen T, Gerwien RW, Hamren S, McKenna MP, et al. (2009) Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 32: 1207-1212.
26. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, et al. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373: 2215-2221.